Should we stop taking thiazides to prevent kidney stones?

Published Date: 08 Mar 2023

"Thiazide is the standard treatment for calcium stones, so this [new research] has the potential to upset the basket," one observer said.

Read Full News

Latest News

Indian Activists Lodge Concerns About Food Warning Proposal

Activists spearheading calls for food labelling said a government proposal to have red warnings only when two concerning nutrients are high created ⁠an "industry-friendly loophole".

EMA Probes Injectable Iron Medicines for Bone Risks

European regulators launched a safety review of injectable iron medicines following reports of severe hypophosphatemia and osteomalacia.

Medicare A1c Coverage Boosts Prediabetes Detection

Since Medicare began covering A1c for diabetes screening in 2024, use of the test and detection of prediabetes have risen dramatically among older adults.

US FDA Is Working With Manufacturers to Boost Estrogen Patch Supply Amid Access Concerns

The U.S. health regulator said on Thursday it is working with all six manufacturers to increase the supply of estradiol transdermal patches, ⁠used to treat menopause...

GLP-1 Meds Linked to Symptomatic Remission in UC

GLP-1 receptor agonist therapy is linked to higher symptomatic remission rates among patients with ulcerative colitis, with benefits appearing independent of weight loss.

Keto Diet Outperforms Others in Liver Health in Obesity

Liver health improves more on a very-low-carbohydrate ketogenic diet than on a Mediterranean or very-low-fat plant-forward diet.

Todays Updates

FDA Approves Camizestrant for ESR1-Mutated Breast Cancer

The accelerated approval enables an endocrine therapy switch when the ESR1 resistance mutation is detected, rather than waiting for evidence of disease progression.

Todays Updates

FDA Approves Camizestrant for ESR1-Mutated Breast Cancer

The accelerated approval enables an endocrine therapy switch when the ESR1 resistance mutation is detected, rather than waiting for evidence of disease progression.

Latest News

Activists spearheading calls for food labelling said a government proposal to have red warnings only when two concerning nutrients are high created ⁠an "industry-friendly loophole".

European regulators launched a safety review of injectable iron medicines following reports of severe hypophosphatemia and osteomalacia.

Since Medicare began covering A1c for diabetes screening in 2024, use of the test and detection of prediabetes have risen dramatically among older adults.

The U.S. health regulator said on Thursday it is working with all six manufacturers to increase the supply of estradiol transdermal patches, ⁠used to treat menopause...

GLP-1 receptor agonist therapy is linked to higher symptomatic remission rates among patients with ulcerative colitis, with benefits appearing independent of weight loss.

Liver health improves more on a very-low-carbohydrate ketogenic diet than on a Mediterranean or very-low-fat plant-forward diet.

News All Time

Novo Nordisk Launches Wegovy Weight-Loss Pill in Germany

Novo Nordisk has launched its Wegovy pill in Germany, a spokesperson for the Danish drugmaker said on Tuesday.

Contraceptives Affect Steroid Profiles in Females With CAH

Combined oral contraceptives reduce plasma and urinary androgen levels and increase total cortisol levels in adolescent and young females with congenital adrenal hyperplasia.

Thyroid Shifts in Midlife Women? Blame Aging, Not Menopause

Thyroid problems in midlife women may have less to do with menopause than doctors think, and more to do with simply getting older, a new study suggests.

Thyroid Hormone Receptor Beta Agonist Cuts Liver Fat in MASH

A selective thyroid hormone receptor beta agonist demonstrates dose-dependent reductions in hepatic fat among adults with metabolic dysfunction-associated steatohepatitis in a phase 2 trial.

How Female Biology Could Solve the Mystery of Longevity

Why do women live longer than men? An evolutionary question sparks a new hypothesis that dovetails with a growing movement in longevity research.

Food Noise, Weight Stigma, and Managing Obesity

Why doesn’t food noise go quiet for everyone on GLP-1s? Why is the bias against them getting louder? And what does long-term obesity management actually look like?

Diabetes Technology Helps T1D but Also Adds Burdens

A qualitative survey finds both expected and less-appreciated hurdles with the use of insulin pumps, CGMs, and automated insulin delivery systems.

Over-the-Counter Continuous Glucose Monitors: Okay for Kids?

A pediatric endocrinologist raises questions about use in youth without diabetes.

New Breathalyzer Detects When Your Body Is Burning Fat

A hand-held device that measures acetone levels in your breath — signaling ketosis — matched mass spectrometry tests for accuracy. But clinical uses may be limited for now.

Lumbar CT Surpasses MRI in Vertebral Bone Quality Assessment

Lumbar CT attenuation measurements outperform MRI-derived vertebral bone quality scores for diagnosing osteopenia and osteoporosis in degenerative spinal populations.

Traditional Chinese Medicines Plus Metformin Improve A1c

In a phase 3 trial, adding a combo of two traditional Chinese meds to metformin reduced A1c and improved lipid measure in patients with T2D whose glycemic control was inadequate with metformin alone.

One Ultrasound Scan Flags Both MASH and Liver Scarring

A novel ultrasound-derived score combined with liver stiffness measurement can identify both MASH and fibrosis, potentially reducing the need for biopsy.

Surprising Signal for Semaglutide in Bipolar Disorder

The GLP-1 semaglutide was linked to fewer psychiatric hospitalizations in patients with bipolar disorder, raising the possibility of benefits beyond weight loss and glycemic control.

T2D Linked to Brain Thinning in Older Adults

Older adults with type 2 diabetes have faster cortical thinning in several brain regions and greater decline in processing speed, a study finds.

The Hidden Cost of Daily Steroids in Duchenne Dystrophy

Boys with Duchenne muscular dystrophy on daily corticosteroids maintained walking ability 4 years longer than those on intermittent treatment, but at what cost to their bone health and growth?

Surgery Underused in Primary Hyperparathyroidism Care

Two thirds of patients with primary hyperparathyroidism have or develop end-organ damage, but only 20% undergo parathyroidectomy, a national cohort study shows.